Cancer cell-derived TGF-β can promote tumour growth by triggering angiogenesis, epithelial–mesenchymal transition and the matrix metalloproteinase (MMP) system for ECM degradation3, 4, 5, 6. Here, TGFB1 is linked to neoplasm.